The Impact of Sugammadex on Ileus After Abdominal Wall Reconstruction

PHASE4Active, not recruitingINTERVENTIONAL

Enrollment

184

Participants

Timeline

Start Date

January 15, 2024

Primary Completion Date

May 30, 2025

Study Completion Date

June 30, 2025

Conditions

Hernia, VentralIleus

Interventions

DRUG

Neostigmine / Glycopyrrolate

Patients will receive standard of care for reversal of neuromuscular blockade

DRUG

Sugammadex

Patients will receive sugammadex for reversal of neuromuscular blockade

Trial Locations (1)

Cleveland Clinic Center for Abdominal Core Health, Cleveland